Skip to content

Personalized Nutrition and EHealth: Lifestyle Intervention (LION) Study for Weight Loss Maintenance

Lifestyle Intervention Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04023942
Acronym
LION
Enrollment
272
Registered
2019-07-18
Start date
2019-07-17
Completion date
2024-02-29
Last updated
2024-12-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Keywords

Obesity, Weight loss, Weight maintenance, Lifestyle intervention, Dietary intervention, Formula diet, App, Newsletter, Digital tool, Low carb, Low fat, Meal challenges

Brief summary

Despite standardized intervention strategies, weight loss and weight loss maintenance largely differ from person to person. Factors which may contribute to these individual differences is current object of research. In order to investigate predictors and barriers for weight management and to investigate two different dietary interventions and two different digital tools for weight maintenance, the LION-Study was designed as follows: Step I (screening, baseline phenotyping), step II (weight loss intervention with formula diet), step III (weight maintenance intervention with 4 intervention groups: low carb/newsletter; low carb/app; low fat/newsletter; low fat/app) and step IV (follow-up). Participants are required to attend visits at seven time points. At screening (month 0) a telephone-based screening interview takes place, in order to test eligibility of the potential participant. If the person is eligible, two consecutive baseline face-to-face visits are planned during step I. After completion of the eight weeks weight loss intervention (month 3), an additional visit takes place followed by three consecutive visits in the weight maintenance step (month 6, 9 and 15). The study ends with a final visit after the follow-up (month 27). Additional contacts (face-to-face and telephone) take place during the weight loss intervention step. Participants will regularly receive a bag with the required formula diet meals. During these pick up appointments, the study team actively get in face-to-face contact with participants. At the different visits, data are collected by questionnaires, medical investigations (e.g. MRI, motor function, resting metabolic rate), blood withdrawal as well as urine, feces and saliva sampling. Primary objective is to evaluate the effect of two diets (low carb/low fat) and two digital tools (app/newsletter) on long-term weight loss maintenance 12 months after weight loss. Secondary objective is to identify genetic, epigenetic, physiological, psychological and lifestyle factors that predict the success of weight loss and weight loss maintenance.

Detailed description

Step I - Screening and baseline phenotyping When a potential suitable participant is interested, a screening interview to check eligibility will take place by phone after oral agreement is given. The structured screening interview is carried out by means of a questionnaire in the format of a Case Report Form (CRF). Suitable persons are provided with participant´s information and data protection sheet and with the declaration of consent. Sufficient time for consideration is given between the screening interview and visit 1A, where written consent is signed. After the telephone-based screening interview, eligible participants are required to provide written consent. Participants will undergo clinical examinations at two visits (V1A + V1B), serving primarily for phenotyping as well as for detection of potentially unknown exclusion criteria. The order of some measurements carried out during V1A and V1B as well as the type of lipid challenge is randomized. Data collection V1A: * Resting metabolic rate * Metabolic response to meal challenge * Anthropometry * Vital parameters * Blood parameters * Clinical, lifestyle (nutrition, physical activity), psychological, environmental and social factors (questionnaires and protocols) * Sampling of blood samples for further research questions Data collection V1B: * Metabolic response to meal challenge * Vital parameters * Blood parameters * Urine parameters * Hand Strength Measurement * Clinical, lifestyle (nutrition, physical activity), psychological, environmental and social factors (questionnaires and protocols) * Sampling of blood, urine and saliva * Optional: Adipose tissue distribution by MRI measurement; parameters for physical strength, motor function and body static condition; 24h urine collection; fecal samples Step II - Weight loss intervention Once participant is still deemed eligible after V1A and V1B, the formula-based low calorie diet (LCD) starts as weight loss intervention. Formula products will be provided once per week. An additional daily intake of 200 g raw or cooked non-starchy vegetables is allowed. Participants fulfill a food diary to record eaten products including drinks and vegetables and to record well-being or side effects. Furthermore, participants are phenotyped by a continuous glucose measurement during the first four weeks of intervention. Data collection V2: * Anthropometry * Vital parameters * Blood and urine parameters * Clinical, lifestyle (nutrition, physical activity), psychological, environmental and social factors (questionnaires and protocols) * Resting metabolic rate * Hand strength measurement * Documentation of safety * Continuous glucose measurement * Sampling of blood, urine, and saliva * Optional: Adipose tissue distribution by MRI measurement; parameters for physical strength, motor function and body static condition; 24h urine collection; fecal samples Step III - Weight maintenance intervention If weight loss is \> 4 kg after eight weeks, the participant is eligible for randomization into one of the following four weight maintenance intervention arms: Low carb - App-based group Low carb - Newsletter-based group Low fat - App-based group Low fat - Newsletter-based group Data collection V3A: * Anthropometry * Blood and urine parameters * Clinical, lifestyle (nutrition, physical activity), psychological, environmental and social factors (questionnaires and protocols) * Documentation of safety * Sampling of blood and urine samples for further research questions, e.g. metabolic profile (to be confirmed) * Optional: 24h urine collection Data collection V3B: * Anthropometry * Blood parameters * Clinical, lifestyle (nutrition, physical activity), psychological, environmental and social factors (questionnaires and protocols) * Documentation of safety * Sampling of blood samples for further research questions, e.g. metabolic profile (to be confirmed) Data collection V3C: * Anthropometry * Blood and urine parameters * Resting metabolic rate * Vital parameters * Clinical, lifestyle (nutrition, physical activity), psychological, environmental and social factors (questionnaires and protocols) * Documentation of safety * Hand strength measurement * Sampling of blood, urine, and saliva * Optional: Adipose tissue distribution by MRI measurement; parameters for physical strength, motor function and body static condition; 24h urine collection; fecal samples Step IV - Follow-up During follow-up, all participants receive the same newsletters with nutritional information every 3 months (independent of weight maintenance intervention group). Further weight management is carried out by self-help. Data collection V4: * Anthropometry * Vital parameters * Blood parameters ( * Clinical, lifestyle (nutrition, physical activity), psychological, environmental and social factors (questionnaires and protocols) * Resting metabolic rate * Sampling of blood

Interventions

BEHAVIORALWeight maintenance intervention

Weight maintenance intervention (52 weeks): After randomization, participants will follow either a low carb or a low fat diet and get nutritional assistance either by an app or a newsletter, based on the group they got randomized to (low carb/app, low carb/newsletter, low fat/app, low fat/newsletter).

Sponsors

Technical University of Munich
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

This clinical study is a single-center 2\*2 factorial randomized trial. For the weight maintenance step, participants will be randomized into one of the four weight maintenance intervention arms.

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Age: 18 - 65 years * BMI: 30,0 - 39,9 kg/m2 * Owner of a smartphone * Caucasian * No severe diseases * Informed written consent

Exclusion criteria

* Diabetes mellitus * Severe cardiovascular and/or respiratory disease * Untreated high blood pressure * Severe kidney disease * Active cancer (or in remission) * Inflammatory bowel disease * Severe chronic infections and/or inflammations * Severe mental-health disorders * Neurodegenerative disorders * Endocrine diseases * Lipedema * Pregnancy and lactation * Vigorous weight fluctuations (\> 5 kg) in the last 3 months * Immobility * Surgery in the last 3 months * Participation in other intervention studies * Carrier of pace makers * Blood donation or transfusion in the last 3 months

Design outcomes

Primary

MeasureTime frameDescription
Weight maintenance 12 months after weight loss intervention15 monthsBody weight change in kg and % (from baseline weight)

Secondary

MeasureTime frameDescription
Glucosemonth 0, 3, 6, 9, 12, 15, 27Change in glucose in mg/dl
Insulinmonth 0, 3, 6, 9, 12, 15, 27Change in insulin in µU/ml
Insulin response on meal challengesmonth 0Insulin response at different time points during meal challenge in µU/ml
Lipidsmonth 0, 3, 6, 9, 12, 15, 27Change in blood lipids (total cholesterin, triglyzeride, HDL cholesterin, LDL cholesterin - highly correlated to each other) in mg/dl
Weight change after eight weeks of formula dietmonth 3Body weight in kg and % (from baseline weight)
Resting metabolic ratemonth 0, 3, 15, 27Resting metabolic rate in kilocalories / 24 hours
Magnetic resonance imaging (MRI)month 0, 3, 15, 27MRI data (organ volume, proton density fat fraction)
Glucose response on meal challengesmonth 0Glucose response at different time points during meal challenge in mg/dl
Lipid response on meal challengesmonth 0Lipid (total cholesterin, triglyzeride, HDL cholesterin, LDL cholesterin - highly correlated to each other) response at different time points during meal challenge in mg/dl
Leptinmonth 0, 3, 6, 9, 12, 15, 27Change in leptin in ng/ml

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 17, 2026